Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review
Muluneh Assefa, Azanaw Amare Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Muluneh Assefa, Tel +251945572632, Email mulunehassefa2010@gmail.comAbstract: Biofilm-related...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-08-01
|
| Series: | Infection and Drug Resistance |
| Subjects: | |
| Online Access: | https://www.dovepress.com/biofilm-associated-multi-drug-resistance-in-hospital-acquired-infectio-peer-reviewed-fulltext-article-IDR |
| _version_ | 1818482341052416000 |
|---|---|
| author | Assefa M Amare A |
| author_facet | Assefa M Amare A |
| author_sort | Assefa M |
| collection | DOAJ |
| description | Muluneh Assefa, Azanaw Amare Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Muluneh Assefa, Tel +251945572632, Email mulunehassefa2010@gmail.comAbstract: Biofilm-related multi-drug resistance (MDR) is a major problem in hospital-acquired infections (HAIs) that increase patient morbidity and mortality rates and economic burdens such as high healthcare costs and prolonged hospital stay. This review focuses on the burden of bacterial biofilm in the hospital settings, their impact on the emergence of MDR in the HAIs, biofilm detection methods, recent approaches against biofilms, and future perspectives. The prevalence of biofilm-associated MDR among HAIs ranges from 17.9% to 100.0% worldwide. The predominant bacterial isolates causing HAIs in recently published studies were S. aureus, A. baumannii, K. pneumoniae, and P. aeruginosa. In addition to the use of qualitative and quantitative methods to detect biofilm formation, advanced PCR-based techniques have been performed for detecting biofilm-associated genes. Although there are suggested therapeutic strategies against biofilms, further confirmation of their efficacy for in vivo application and antibiotics targeting biofilm-associated genes/proteins to minimize treatment failure is required for the future.Keywords: biofilm, multi-drug resistance, hospital-acquired infections |
| first_indexed | 2024-12-10T11:46:27Z |
| format | Article |
| id | doaj.art-c8a85cd1b34d4113ae0657a464a8dc5a |
| institution | Directory Open Access Journal |
| issn | 1178-6973 |
| language | English |
| last_indexed | 2024-12-10T11:46:27Z |
| publishDate | 2022-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Infection and Drug Resistance |
| spelling | doaj.art-c8a85cd1b34d4113ae0657a464a8dc5a2022-12-22T01:50:04ZengDove Medical PressInfection and Drug Resistance1178-69732022-08-01Volume 155061506877820Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A ReviewAssefa MAmare AMuluneh Assefa, Azanaw Amare Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Muluneh Assefa, Tel +251945572632, Email mulunehassefa2010@gmail.comAbstract: Biofilm-related multi-drug resistance (MDR) is a major problem in hospital-acquired infections (HAIs) that increase patient morbidity and mortality rates and economic burdens such as high healthcare costs and prolonged hospital stay. This review focuses on the burden of bacterial biofilm in the hospital settings, their impact on the emergence of MDR in the HAIs, biofilm detection methods, recent approaches against biofilms, and future perspectives. The prevalence of biofilm-associated MDR among HAIs ranges from 17.9% to 100.0% worldwide. The predominant bacterial isolates causing HAIs in recently published studies were S. aureus, A. baumannii, K. pneumoniae, and P. aeruginosa. In addition to the use of qualitative and quantitative methods to detect biofilm formation, advanced PCR-based techniques have been performed for detecting biofilm-associated genes. Although there are suggested therapeutic strategies against biofilms, further confirmation of their efficacy for in vivo application and antibiotics targeting biofilm-associated genes/proteins to minimize treatment failure is required for the future.Keywords: biofilm, multi-drug resistance, hospital-acquired infectionshttps://www.dovepress.com/biofilm-associated-multi-drug-resistance-in-hospital-acquired-infectio-peer-reviewed-fulltext-article-IDRbiofilmmulti-drug resistancehospital-acquired infections |
| spellingShingle | Assefa M Amare A Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review Infection and Drug Resistance biofilm multi-drug resistance hospital-acquired infections |
| title | Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review |
| title_full | Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review |
| title_fullStr | Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review |
| title_full_unstemmed | Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review |
| title_short | Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review |
| title_sort | biofilm associated multi drug resistance in hospital acquired infections a review |
| topic | biofilm multi-drug resistance hospital-acquired infections |
| url | https://www.dovepress.com/biofilm-associated-multi-drug-resistance-in-hospital-acquired-infectio-peer-reviewed-fulltext-article-IDR |
| work_keys_str_mv | AT assefam biofilmassociatedmultidrugresistanceinhospitalacquiredinfectionsareview AT amarea biofilmassociatedmultidrugresistanceinhospitalacquiredinfectionsareview |